InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,634.58
(
0.03%
)
US TECH 100
18,948.04
(
0.04%
)
Dow Jones
41,606.18
(
0.00%
)
Brent Oil
72.70
(
-0.85%
)
Bitcoin
59,807.43
(
-0.82%
)
Post# of 253144
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

rkrw

Send PM Follow Ignore
Followers 45
Posts 3204
Boards Moderated 0
Alias Born 12/29/2003

rkrw

Member Level

Re: DewDiligence post# 20215

Monday, 12/12/2005 10:08:53 AM

Monday, December 12, 2005 10:08:53 AM

Post# of 253144
For whatever reason there's been a ton of shorts in myog. So it could be a lot of short covering. otoh the data looks to be best in class, superior efficacy and safety. Actelions tracleer is running at >$500M/year. If the data holds up, the move may well be justified in the long term imo. And as you say this isn't even myog's most important drug. myog bottomed at around $6 bucks I think.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up